Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Diane St. Germain"'
Autor:
Judith O, Hopkins, Christa, Braun-Inglis, Sofia, Guidice, Meg, Wells, Kiran, Moorthi, Jeffrey, Berenberg, Diane, St Germain, Supriya, Mohile, Matthew F, Hudson
Publikováno v:
J Natl Cancer Inst Monogr
In April 2021, the National Cancer Institute (NCI) Division of Cancer Prevention collaborated with the NCI Division of Cancer Treatment and Diagnosis to produce a virtual workshop that developed recommendations for enhancing NCI-sponsored clinical tr
Autor:
Dudith Pierre-Victor, Iman K. Martin, Brenda Adjei, Mary Shaw-Ridley, Bruce Rapkin, Marjorie Good, Diane St. Germain, Bernard Parker, Paul F. Pinsky, Worta McCaskill-Stevens
Publikováno v:
Journal of the National Medical Association.
Publikováno v:
Supportive Care in Cancer. 30:4739-4746
Autor:
Diane St. Germain, Supriya G Mohile
Publikováno v:
J Natl Cancer Inst Monogr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01796ca194c564f25d85e7d58fcf1e0b
https://europepmc.org/articles/PMC9949569/
https://europepmc.org/articles/PMC9949569/
Publikováno v:
Cancer. 126:4602-4613
Background To the authors' knowledge, the empiric identification of agents and interventions to mitigate chemotherapy-induced peripheral neuropathy (CIPN) has resulted in only 1 agent that modestly mitigates it and no agents or interventions that pre
Autor:
Worta McCaskill-Stevens, Lori M. Minasian, Grace Mishkin, Diane St. Germain, Andrea Denicoff, Joseph Kelaghan, Ann M. O'Mara, Andrea D. Torres
Publikováno v:
Cancer. 126:2687-2693
Background The importance of capturing and reporting health-related quality of life (HRQOL) in clinical trials has been increasingly recognized in the oncology field. As a result, the National Cancer Institute (NCI) began to provide support for corre
Autor:
Brenda A. Adjei, Manami Bhattacharya, Diane St. Germain, Alexis Bakos, Worta McCaskill-Stevens
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 32:B120-B120
Background/Purpose: Clinical trials offer an underutilized platform to address health disparities. Most disparities-related work in clinical trials has focused on improving patient diversity, rather than on the research questions to reduce disparitie
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 30(6)
This study was conducted to describe the portfolio of symptom science research conducted through the community oncology network supported by the US National Cancer Institute during the 12-year period 2008 to 2019.The National Cancer Institute conduct
Autor:
Ethan Basch, Ann M. O'Mara, Lori M. Minasian, Kimberly Shoenbill, Deborah Schrag, Lauren J. Rogak, Ashley C. Griffin, Diane St. Germain, Deborah Watkins Bruner, Amylou C. Dueck, Sandra A. Mitchell, Paul Baumgartner, Amy P. Abernethy, Arlene E. Chung
Publikováno v:
Journal of the American Medical Informatics Association. 26:276-285
Objective The study sought to describe patient-entered supplemental information on symptomatic adverse events (AEs) in cancer clinical research reported via a National Cancer Institute software system and examine the feasibility of mapping these entr
Publikováno v:
CancerReferences. 127(10)
Background Clinical trial patient accrual continues to be challenging despite the identification of multiple physician, patient, and system barriers. Expanded collection of demographic data, including socioeconomic status (employment, income, educati